Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F0LV4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 5, 2026, to AmerisourceBergen Drug Corp supplies 30-count unit dose packages of Vyndamax 61 mg capsules to the Defense Logistics Agency (DLA) with a ceiling value of $14,592.57 and an ultimate completion date of January 27, 2026. The award is unclassified as a set-aside contract and utilizes firm fixed-price pricing. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive contract portfolio with DLA demonstrates its capability to competitively deliver a comprehensive range of pharmaceutical products across multiple therapeutic domains. Vyndamax (tafamidis) is a specialized medication used in the treatment of transthyretin amyloidosis, reflecting the company's role in supplying specialized medications to support military and veteran healthcare systems. The award was made through open competition with no set-aside designation, consistent with AmerisourceBergen's track record of successfully competing for federal pharmaceutical contracts.
Quick answers
Who was awarded contract SPE2DR26F0LV4?
SPE2DR26F0LV4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F0LV4 worth?
The government has obligated $14,593 on SPE2DR26F0LV4.
Is contract SPE2DR26F0LV4 an order under another contract?
Yes. SPE2DR26F0LV4 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0LV4 competed?
The extent of competition for SPE2DR26F0LV4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award